Sterling Pharma Solutions, announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million investment to increase GMP bioconjugation capacity.
ProductLife Group (PLG) announced the acquisition of Callisto, a UK-based consultancy specialising in Regulatory Affairs (RA), Pharmacovigilance (PV) and GMDP services within multiple regulated sectors.
Ardena announced a expansion of its bioanalytical services in the Netherlands, including a new bioanalytical lab at Ardena’s Pivot Park facility in Oss and new GLP capabilities in Assen.
Logical Biological has settled into larger, upgraded laboratory space at Discovery Park, marking its third move within the science and innovation campus.
Naobios and Sumagen Canada Inc, a Korean-Canadian biotechnology company developing an HIV-1 vaccine candidate, announced the production of the HIV-1 vaccine candidate at bench scale.
AstraZeneca’s drug Fasenra (benralizumab) has been approved in the European Union as an additional treatment for adults with eosinophilic granulomatosis with polyangiitis (EGPA).
CluePoints announced that Richard Young has been appointed as its new chief strategy officer who will ensure CluePoints’ continued growth and development as a provider of integrated data review software.
Takeda announced positive interim results from a Phase 3-enabling proof-of-concept study for mezagitamab (TAK-079), an anti-CD83 monoclonal antibody, in patients with primary immunoglobulin A nephropathy (IgAN).
Coronado Research announced that Professor Jennifer Visser-Rogers has been appointed as chief scientific officer, bringing with her a broad portfolio of scientific achievement across academia and industry.
ApiJect announced it has been awarded an initial grant of $425,000 from the Bill & Melinda Gates Foundation to develop low-cost blow-fill-seal prefilled injection devices to enhance access in Low- and Middle-Income Countries (LMICs).
